Unleashing the Power of Induced Pluripotent stem Cells in in vitro Modelling of Lesch-Nyhan Disease
- 4 November 2024
- journal article
- research article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 21 (2) , 304-318
Abstract
Lesch-Nyhan disease (LND) is a monogenic rare neurodevelopmental disorder caused by a deficiency in hypoxanthine–guanine phosphoribosyltransferase (HPRT), the key enzyme of the purines salvage pathway. Beyond its well-documented metabolic consequences, HPRT deficiency leads to a distinctive neurobehavioral syndrome characterized by motor disabilities, cognitive deficits, and self-injurious behavior. Although various cell and animal models have been developed to investigate LND pathology, none have adequately elucidated the underlying mechanisms of its neurological alterations. Recent advances in human pluripotent stem cell research and in vitro differentiation techniques have ushered in a new era in rare neurodevelopmental disorders research. Pluripotent stem cells, with their ability to propagate indefinitely and to differentiate into virtually any cell type, offer a valuable alternative for modeling rare diseases, allowing for the detection of pathological events from the earliest stages of neuronal network development. Furthermore, the generation of patient-derived induced pluripotent stem cells using reprogramming technology provides an opportunity to develop a disease-relevant model within the context of a patient-specific genome. In this review, we examine current stem cell-based models of LND and assess their potential as optimal models for exploring key pathological molecular events during neurogenesis and for the discovering novel treatment options. We also address the limitations, challenges, and future prospects for improving the use of iPSCs in LND research. Graphical AbstractKeywords
This publication has 104 references indexed in Scilit:
- Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeuticsBiotechnology and Bioengineering, 2023
- Description of the Lesch‐Nyhan neurobehavioral disorder and its management through participant observation of three young individualsJIMD Reports, 2020
- Neurodevelopmental disordersWIREs Cognitive Science, 2016
- Do clinical features of Lesch‐Nyhan disease correlate more closely with hypoxanthine or guanine recycling?Journal of Inherited Metabolic Disease, 2015
- Loss of dopamine phenotype among midbrain neurons inLesch–Nyhan diseaseAnnals of Neurology, 2014
- Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch‐Nyhan patientsJournal of Inherited Metabolic Disease, 2012
- Update on the Phenotypic Spectrum of Lesch-Nyhan Disease and its Attenuated VariantsCurrent Rheumatology Reports, 2011
- Use of intact erythrocytes in the diagnosis of inherited purine and pyrimidine disordersJournal of Inherited Metabolic Disease, 1986
- Activities of Amidophosphoribosyltransferase and Purine Phosphoribosyltransferases in Developing Rat Brain1980
- Monoamine oxidase activity reduced in cultured human fetal cells deficient in hypoxanthine-guanine phosphoribosyltransferase activityBiochemical Genetics, 1978